Ambev SA Sponsored ADR Stock News

Ambev shares have been an incredibly weak performer in recent years. Currency depreciation has hurt dollar returns and the company's margins, with the latter exacerbated by recent cost inflation and market dynamics in Brazil. These shares have also suffered a pretty severe valuation de-rating. However, at 12x earnings and sitting on net cash, Ambev looks cheap.

MoneyShow presents top investment ideas for 2025 from their contributors. This year's edition presents a broad mix of theme-based stock picks, momentum-driven high-flyers and beaten-up stocks with turnaround potential, along with some speculative plays and ETFs. Part 3 includes Altria Group, Heico, Intel, Palantir Technologies, ProShares UltraShort S&P 500 ETF, Rivian and Ambev SA, among others.

The 4-factor dividend growth portfolio is a strategy that leverages the stock selection process of Schwab U.S. Dividend Equity ETF with a few minor twists. The portfolio is experiencing its worst start to any FY since its inception, trailing both the S&P 500 and SCHD. Since its inception, the portfolio has generated a CAGR of 17.69%, and is outperforming SCHD by 8.52%.

Ambev S.A. offers strong revenue growth, high operating margins, and a solid balance sheet with minimal debt, making it a compelling investment despite Brazil's economic challenges. ABEV is trading at record low valuation multiples, with a significant net cash position and high capital returns, including a 5.8% dividend yield. Recent earnings show positive trends with net sales up 4.9%, improve...

Ambev S.A. (NYSE:ABEV ) Q3 2024 Earnings Conference Call October 31, 2024 11:30 AM ET Company Participants Jean Jereissati - Chief Executive Officer Lucas Lira - Chief Financial and Investor Relations Officer Conference Call Participants Isabella Simonato - Bank of America Thiago Duarte - BTG Robert Ottenstein - Evercore Lucas Ferreira - JPMorgan Henrique Brustolin - Bradesco BBI Guilherme Palh...

Ambev S.A. shows strong stability and innovation but faces challenges from competitive pressure, declining profitability, and shifting consumer preferences. The company has a solid balance sheet, low debt, and a high dividend yield, making it a potential defensive investment. Ambev's fundamentals, including EPS, ROE, and ROIC, indicate a recovery from Covid lows, suggesting the stock may be und...

A strong yield doesn't mean much if the underlying payment can't be sustained.

Ambev is a quintessential value stock. It is cheap relative to where it has traded historically, its peers, the consumer staples sector, and the market. The stock has clean financials and operating results, which increase its margin of safety for investors and reduce the odds it is a value trap.